SpectrumX Holdings ready for first in-human clinical trial | News Direct

SpectrumX Holdings ready for first in-human clinical trial

SpectrumX Holdings UK Ltd
Digital Asset Direct by SpectrumX Holdings UK Ltd
Download PDF Download multimedia

facebook icon linkedin icon twitter icon pinterest icon email icon London, UK | December 13, 2022 04:33 AM Eastern Standard Time

SpectrumX Holdings UK co-founder and CEO Damien Hancox visited Proactive's London studio to talk about how SpectrumX has performed during 2022. He gives his view of how the company has been evolving and reveals what investors can expect from the coming year. Hancox describes 2022 as "exciting and busy" and that it is now ready to move forward with its first in-human clinical trial.

 

Contact Details

 

Proactive

 

Proactive UK Ltd

 

+44 20 7989 0813

 

uk@proactiveinvestors.com

DOWNLOAD

project media

Tags

HealthPharma & BiotechHypochlorous AcidHOCl
News Direct Logo
Follow us on Facebook Follow us on LinkedIn
Get the latest from News Direct
Contact Us Pricing
Why News Direct
About us Features News Hub
Resources
Terms of Use Privacy Policy
newsdirect.com © 2025 News Direct Corp. All rights reserved. News Direct is a registered trademark.